Sustainability Report

Overview

The report presents Glenmark Pharmaceuticals Limited's FY2020-21 ESG performance across environmental, social and governance themes. It sets a carbon-neutral ambition for Scope 1 and Scope 2 emissions by 2030 and describes a dedicated ESG Board committee. Environmental disclosures include quantified Scope 1, Scope 2 and Scope 3 inventories, energy consumption, water consumption and waste-management performance. The report also details workforce, human-rights, occupational-safety and community programs, and includes an independent DNV GL assurance statement.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020-2021
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services